Measuring quality of life in patients with schizophrenia: An overview

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 13, Issue 3, 2013, Pages 343-349

  Boyer, Laurent ^a   Baumstarck, Karine ^a   Boucekine, Mohamed ^a   Blanc, Julien ^a   Lançon, Christophe ^a   Auquier, Pascal ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

conceptual aspects; psychometrics; quality of life; schizophrenia

Indexed keywords

BRAIN ELECTROPHYSIOLOGY; CLINICAL DECISION MAKING; COGNITION; COGNITIVE DEFECT; ENVIRONMENTAL FACTOR; EVENT RELATED POTENTIAL; HUMAN; NEUROIMAGING; PATIENT ATTITUDE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; REVIEW; SCHIZOPHRENIA; WELLBEING;

COOPERATIVE BEHAVIOR; DECISION MAKING; HEALTH CARE COSTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 84885109849     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.13.15     Document Type: Review

References (93)

1. Hofer A, Baumgartner S, Bodner T et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur. Psychiatry 20(5-6), 395-402 (2005)
2. Hofer A, Baumgartner S, Edlinger M et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur. Psychiatry, 20(5-6), 386-394 (2005)
3. Kasckow JW, Twamley E, Mulchahey JJ et al. Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res. 103(1), 69-78 (2001)
4. Lehman AF. The well-being of chronic mental patients. Arch. Gen. Psychiatry 40(4), 369-373 (1983)
5. Lehman AF. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval. Program Plann. 6(2), 143-151 (1983)
6. Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C. Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur. Psychiatry 20(7), 510-519 (2005)
7. Cramer JA, Rosenheck R, Xu W, Thomas J, Henderson W, Charney DS. Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophr. Bull. 26(3), 659-666 (2000)
8. Awad AG, Voruganti LN. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics 30(3), 183-195 (2012). •• Provides an update and revisits the development of the construct of quality of life (QoL) and its measurement as applied to schizophrenia
9. Halyard MY, Frost MH, Dueck A. Integrating QoL assessments for clinical and research purposes. Curr. Probl. Cancer 30(6), 319-330 (2006)
10. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QoL data really any different than other medical testing? Curr. Probl. Cancer 30(6), 261-271 (2006)
11. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc. Sci. Med. 60(4), 833-843 (2005)
12. Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br. J. Psychiatry 180, 101-103 (2002)
13. Auquier P, Boyer L. Measuring patients? views: between enthusiasm and reality. Eur. J. Cardiothorac. Surg. 41(4), 829-830 (2012)
14. Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev. Pharmacoecon. Outcomes Res. 11(5), 491-493 (2011)
15. Calman KC. Quality of life in cancer patients-an hypothesis. J. Med. Ethics 10(3), 124-127 (1984)
16. Wood-Dauphinee S, Williams JI. Reintegration to Normal Living as a proxy to quality of life. J. Chronic Dis. 40(6), 491-502 (1987)
17. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual. Life Res. 6(1), 21-26 (1997)
18. Ritsner M, Gibel A, Ratner Y. Determinants of changes in perceived quality of life in the course of schizophrenia. Qual. Life Res. 15(3), 515-526 (2006)
19. Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychol. Med. 28(5), 1221-1230 (1998)
20. Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C. [Relationship between insight and self-reported quality of life among shizophrenic patients]. Encephale. 37(3), 162-171 (2011)
21. Boyer L, Aghababian V, Richieri R et al. Insight into illness, neurocognition and quality of life in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 36(2), 271-276 (2012)
22. Karow A, Pajonk FG, Reimer J et al. The dilemma of insight into illness in schizophrenia: self-and expert-rated insight and quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 258(3), 152-159 (2008)
23. Kurtz MM, Tolman A. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship? Schizophr. Res. 127(1-3), 157-162 (2011)
24. Xiang YT, Wang Y, Wang CY et al. Association of insight with sociodemographic and clinical factors, quality of life, and cognition in Chinese patients with schizophrenia. Compr. Psychiatry 53(2), 140-144 (2012)
25. Boyer L, Richieri R, Faget C et al. Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Res. 202(2), 155-160 (2012). • One of the first studies to propose a neurobiological understanding QoL
26. Semerari A, Carcione A, Dimaggio G et al. How to evaluate metacognitive function in psychotherapy? The metacognition assessment scale its applications. Clin. Psychol. Psychother. 10, 238-261 (2003)
27. Erikson R. Welfare as a planning goal. Acta Sociologica 17(3), 273-288 (1974)
28. Griffin J. Well-being, Its Meaning, Measurement and Moral Importance. Clarendon Press, Oxford, UK (1986)
29. Rawls J. A Theory of Justice. Oxford University Press, Oxford, UK (1971)
30. Sen A. Well-being, agency and freedom. The Dewey lectures 1984. J. Phil. 82(4), 169-221 (1985)
31. Nordenfelt L. Toward a theory of happiness: a subjectivist notion of quality of life. In: Concepts and Measurements of Quality of Life in Health Care. Nordenfelt L (Ed.). Kluwer, Dordrecht (1994)
32. Blanc J. Well-being and Amour propre: completing J. Griffin's account of utility. Presented at: The 11th Conference of the International Society for Utilitarian Studies (ISUS), Lucca, Italy, 23-25 June 2011
33. Leplège A, Hunt S. The problem of quality of life in medicine. JAMA 278(1), 47-50 (1997)
34. Voruganti LN, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia-findings from an in vivo SPECT study. Schizophr. Res. 88(1-3), 179-186 (2006). • One of the first studies to propose a neurobiological understanding of QoL
35. Tolman AW, Kurtz MM. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr. Bull. 38(2), 304-315 (2012)
36. Higuchi Y, Sumiyoshi T, Kawasaki Y, Matsui M, Arai H, Kurachi M. Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300. Schizophr. Res. 101(1-3), 320-330 (2008)
37. Sumiyoshi T, Higuchi Y, Itoh T et al. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Psychiatry Res. 172(3), 180-183 (2009)
38. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc. Sci. Med. 48(11), 1531-1548 (1999)
39. Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann. Oncol. 10(7), 747-749 (1999)
40. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc. Sci. Med. 48(11), 1507-1515 (1999). •• Integrating response shift into QoL research would allow a better understanding of how QoL is affected by changes in health status, and this paper proposes one of the first works on this subject
41. Oort FJ, Visser MR, Sprangers MA. Formal definitions of measurement bias and explanation bias clarify measurement and conceptual perspectives on response shift. J. Clin. Epidemiol. 62(11), 1126-1137 (2009)
42. Barclay-Goddard R, Lix LM, Tate R, Weinberg L, Mayo NE. Response shift was identified over multiple occasions with a structural equation modeling framework. J. Clin. Epidemiol. 62(11), 1181-1188 (2009)
43. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual. Life Res. 15(9), 1533-1550 (2006)
44. EVans S, Huxley P. Adaptation, responseshift and quality of life ratings in mentally well and unwell groups. Qual. Life Res. 14(7), 1719-1732 (2005)
45. Boucekine M, Loundou A, Baumstarck K et al. Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study. BMC Med. Res. Methodol. 13, 20 (2013)
46. Ubel PA, Peeters Y, Smith D. Abandoning the language of 'response shift': a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life. Qual. Life Res. 19(4), 465-471 (2010)
47. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur. J. Cancer 33(1), 20-28 (1997)
48. Acquadro C, Berzon R, Dubois D et al.; PRO Harmonization Group. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6(5), 522-531 (2003)
49. Apolone G, De Carli G, Brunetti M, Garattini S. Health-related quality of life (HR-QoL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QoL measures in drug approval. Pharmacoeconomics 19(2), 187-195 (2001)
50. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur. J. Cancer 45(3), 347-353 (2009)
51. Evenson RC, Vieweg BW. Using a quality of life measure to investigate outcome in outpatient treatment of severely impaired psychiatric clients. Compr. Psychiatry 39(2), 57-62 (1998)
52. Bobes J, García-Portilla P, Sáiz PA, Bascarán T, Bousoño M. Quality of life measures in schizophrenia. Eur. Psychiatry 20(Suppl. 3), S313-S317 (2005)
53. Simeoni MC, Auquier P, Lançon C, Leplege A, Simon-Abbadi S, Guelfi JD. [Critical review of measures of quality of life in schizophrenia]. Encephale. 26(4), 35-41 (2000)
54. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 32(1), 40-66 (1994)
55. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31(3), 247-263 (1993)
56. Stein LI, Test MA. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch. Gen. Psychiatry 37(4), 392-397 (1980)
57. Malm U, May PR, Dencker SJ. Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophr. Bull. 7(3), 477-487 (1981)
58. Baker F, Intagliata J. Quality of life in the evaluation of community support systems. Eval. Program Plann. 5(1), 69-79 (1982)
59. Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health program clients: validating a measure. Community Ment. Health J. 27(1), 43-55 (1991)
60. Lehman AF. A quality of life interview for the chronically mentally ill. Eval. Prog. Planning 11, 51-62 (1988)
61. Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc. Psychiatry Psychiatr. Epidemiol. 32(2), 76-83 (1997)
62. Skantze K. Defining Subjective Quality of Life Goals in Schizophrenia: the Quality of Life Self-Assessment Inventory, QLS 100, a New Approach to Successful Alliance and Service Development. Department of Psychiatry, Sahlgrenka Hospital, University of Gothenburg, Goteborg, Sweden (1993)
63. Awad AG, Hogan TP. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr. Scand. Suppl. 380, 27-32 (1994)
64. Hogan TP, Awad AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol. Med. 22(2), 347-352 (1992)
65. Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual. Life Res. 2(4), 239-251 (1993)
66. Holcomb WR, Morgan P, Adams NA, Ponder H, Farrel M. Development of a structured interview scale for measuring quality of life of the severely mentally ill. J. Clin. Psychol. 49(6), 830-840 (1993)
67. Heinrichs DW, Hanlon TE, Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10(3), 388-398 (1984)
68. Boyer L, Simeoni MC, Loundou A et al. The development of the S-QoL 18: a hortened quality of life questionnaire for patients with schizophrenia. Schizophr. Res. 121(1-3), 241-250 (2010). • The S-QoL
69. Auquier P, Simeoni MC, Sapin C et al. Development and validation of a patientbased health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr. Res. 63(1-2), 137-149 (2003)
70. Nadalet L, Kohl FS, Pringuey D, Berthier F. Validation of a subjective quality of life questionnaire (S.QUA.LA) in schizophrenia. Schizophr. Res. 76(1), 73-81 (2005)
71. McKenna SP. Measuring quality of life in schizophrenia. Eur. Psychiatry 12(Suppl. 3), S267-S274 (1997)
72. Franz M, Fritz M, Gallhofer B, Meyer T. QLiS-development of a schizophreniaspecific quality-of-life scale. Health Qual. Life Outcomes 10, 61 (2012)
73. Gutteling JJ, Busschbach JJ, de Man RA, Darlington AS. Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients. Health Qual. Life Outcomes 6, 97 (2008)
74. Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual. Life Res. 7(1), 85-91 (1998)
75. Takeuchi EE, Keding A, Awad N et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J. Clin. Oncol. 29(21), 2910-2917 (2011)
76. Luckett T, Butow PN, King MT. Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 18(11), 1129-1138 (2009)
77. Nishiyama T, Ozaki N. Measurement limit of quality-of-life questionnaires in psychiatric settings. Qual. Life Res. 19(1), 25-30 (2010)
78. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol. Med. 28(1), 165-172 (1998)
79. Gold SM, Schulz H, Mönch A, Schulz KH, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult. Scler. 9(4), 404-410 (2003)
80. Marrie RA, Miller DM, Chelune GJ, Cohen JA. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult. Scler. 9(6), 621-626 (2003)
81. Baumstarck K, Pelletier J, Aghababian V et al. Is the concept of quality of life releVant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS ONE 7(1), e30627 (2012)
82. Orley J, Saxena S, Herrman H. Quality of life and mental illness. Reflections from the perspective of the WHOQoL. Br. J. Psychiatry 172, 291-293 (1998)
83. Prince PN, Gerber GJ. Measuring subjective quality of life in people with serious mental illness using the SEIQoL-DW. Qual. Life Res. 10(2), 117-122 (2001)
84. Wong JG, Cheung EP, Chen EY et al. An instrument to assess mental patients? capacity to appraise and report subjective quality of life. Qual. Life Res. 14(3), 687-694 (2005)
85. Boyer L, Baumstarck K, Boucekine M et al. Self-report quality of life measure is reliable and valid in patients suffering from schizophrenia with executive impairment. Patient reported outcomes and person centered care in mental health. Presented at: International Center of Mental Health Policy and Economics. Washington, DC, USA, 28-30 September 2012
86. Baumstarck K, Boyer L, Boucekine M et al. Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophr. Res. 147(1), 58-67 (2013)
87. Leucht S, Tardy M, Komossa K et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 379(9831), 2063-2071 (2012)
88. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J. Am. Soc. Nephrol. 12(12), 2797-2806 (2001)
89. Parshall MB, Mapel DW, Rice L, Williams A, O'Reilly J. Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation. Heart Lung 37(5), 356-365 (2008)
90. Sprenkle MD, Niewoehner DE, Nelson DB, Nichol KL. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest 126(1), 81-89 (2004)
91. Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br. J. Psychiatry 184, 346-351 (2004)
92. Ascher-SVanum H, Zhu B, Faries DE et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 10, 2 (2012)
93. Boyer L, Auquier P. The lack of impact of quality-of-life measures in schizophrenia: a shared responsibility? Pharmacoeconomics 30(6), 531-532; author reply 532 (2012)